In the results of PPI analysis, we found that AKT, TNF-α, IL-6, IL-1β, caspase-3, and MMP9 were the core targets of SHD in preventing and treating cisplatin-induced AKI. The gene discussed is MMP9; the disease is acute kidney injury.